Penn Pharma appoints coo

Mark Dean-Netscher joins firm from Catalent

UK-based pharmaceutical services provider Penn Pharma has appointed Mark Dean-Netscher as chief operating officer.

Dean-Netscher will join the company on 16 May with more than 20 years’ experience in the pharmaceutical manufacturing industry to manage this South Wales-headquartered business as it continues to expand and strengthen its international presence.

Dean-Netscher has led Reckitt Benckiser’s global healthcare operation and most recently, was Operations Vice President International and Europe for Catalent.

He will be responsible for overseeing the operation of Penn Pharma’s Specials and global contract manufacturing and development services. This includes analytical services, formulation, clinical trial supplies, logistics and commercial manufacturing and packaging.

You may also like